Sector archive
Healthcare Sector News Archives for 2013
BSE Sensex 74607.71 456.67
(0.62%)
- Zydus Cadila gains on receives tentative approval from USFDA for Doxepin HcI tablets
- Zydus Cadila receives tentative approval from USFDA for Doxepin HcI tablets
- Lupin submits disclosure
- USFDA issues warning letter to Jubilant Life Sciences’ manufacturing facility in Canada
- Fresenius Kabi Oncology trades higher on the BSE
- Fresenius Kabi Oncology puts production from API plant in WB on hold
- Ranbaxy Laboratories reports consolidated net loss of Rs 492.44 crore in Q4
- Fortis Healthcare allots equity shares under ESOP
- Zydus Cadila gets final USFDA approval for Ranitidine HcI injection
- Venus Remedies surges on signing exclusive marketing rights deal for antibiotic Potentox to Adcock
- Venus Remedies signs exclusive marketing rights deal for antibiotic Potentox to Adcock
- Sequent Scientific fixes EGM on March 20, 2013
- Kappac Pharma informs outcome board meeting
- Ranbaxy Laboratories surges on commencing production of Atorvastatin product
- Ranbaxy Laboratories commences production of Atorvastatin product
- Shasun Pharmaceuticals submits disclosure
- Lupin surges as its arm receives USFDA approval for SUPRAX Oral Suspension
- Opto Circuits (India) submits disclosure
- Lupin’s arm receives USFDA approval for SUPRAX Oral Suspension, 500 mg/5mL
- Parikh Herbals informs change in directorate